ETHYL 4-BROMO-3-(BROMOMETHYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLATE, 95.0%, 250mg

mTOR Inhibitor-1>98.0%(HPLC)5mg

2-(4-Fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-3-carbaldehyde, 2g

(4-(OXAZOL-2-YL)PHENYL)METHANAMINE HCL, 95.0%, 250mg

Polyvinylpyrrolidone K 25, 2.5 kg

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole, 97%, 250mg

3-Chlorobenzeneboronic acid, 99.00%, 25g

6-Chloropyrimidine-2,4,5-triamine, 95.0%, 250mg

(1-(4-Bromophenyl)cyclobutyl)methanamine, 95.0%, 250mg

Succinimidyl 7-diethylaminocoumarin-3-carboxylate, 95.0%, 1g

2,5-Dichloro-2,5-dimethyl-hexane, 95.0%, 100g

ethyl 3-(3,4-dichlorophenyl)-1H-pyrazole-5-carboxylate, 1g

7-Bromo-1H-pyrrolo[3,2-c]pyridine-3-carbonitrile, 95+%, 1g